| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/09/2006 | CA2805455A1 Methods and compositions for modulating flowering and maturity in plants |
| 02/09/2006 | CA2762893A1 Method for isolation of transcription termination sequences |
| 02/09/2006 | CA2577140A1 Patterned surfaces with chemical crosslinkers for use in diffraction-based sensing |
| 02/09/2006 | CA2576173A1 Direct activation of atiii in whole blood and plasma |
| 02/09/2006 | CA2575986A1 Method of assuming drug sensitivity to cdk4 inhibitor |
| 02/09/2006 | CA2575557A1 Prognosis of breast cancer patients |
| 02/09/2006 | CA2575552A1 Notch mutations leading to increased receptor signaling |
| 02/09/2006 | CA2575523A1 Methods for determining the potency, specificity, and toxicity of hematopoietic prostaglandin d2 synthase |
| 02/09/2006 | CA2575480A1 Inducible gene expression |
| 02/09/2006 | CA2575433A1 Bacteria detection device, bacteria detection method and bacteria detection kit |
| 02/09/2006 | CA2574917A1 Capture probe design for efficient hybridisation |
| 02/09/2006 | CA2574605A1 Cyclic peptides for treatment of cachexia |
| 02/09/2006 | CA2574598A1 Activated protein c inhibits undesirable effects of plasminogen activator in the brain |
| 02/09/2006 | CA2574496A1 Methods for diagnosis using anti-cytokine receptor antibodies |
| 02/09/2006 | CA2573591A1 Method of in-vitro detection and quantification of hiv dna by quantitative pcr |
| 02/09/2006 | CA2573150A1 Fluorescent lifetime biological detection and imaging using water-stable semiconductor nanocrystals |
| 02/09/2006 | CA2573142A1 Cyclic peptides for treatment of cachexia |
| 02/09/2006 | CA2572638A1 Methods and compositions for treating obesity |
| 02/09/2006 | CA2570323A1 Methods and compositions for modulating hepatocyte growth factor activation |
| 02/09/2006 | CA2568886A1 Compositions and methods for treatment of non-hodgkin's lymphoma |
| 02/08/2006 | EP1624304A1 Probe for detecting and quantifying lipid second messenger and method of detecting and quantifying lipid second messenger using the same |
| 02/08/2006 | EP1624076A1 Quantitative detection of HDV by real-time RT-PCR |
| 02/08/2006 | EP1624075A2 Detection of human papilloma virus |
| 02/08/2006 | EP1624074A1 Markers and methods for detecting prenatal chromosomal abnormalities |
| 02/08/2006 | EP1624073A1 Drug |
| 02/08/2006 | EP1624072A1 Method for the determination of the activity of the Factor VII-activating protease in protein solutions |
| 02/08/2006 | EP1624071A2 Method of detecting viable cells |
| 02/08/2006 | EP1624064A2 Nucleic acids and proteins from streptococcus pneumoniae |
| 02/08/2006 | EP1624059A2 Method of producing nucleic acid molecules with reduced secondary structure |
| 02/08/2006 | EP1624058A2 Methods and compositions for performing template dependent nucleic acid primer extension reactions that produce a reduced complexity product |
| 02/08/2006 | EP1623993A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/08/2006 | EP1623992A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/08/2006 | EP1623991A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/08/2006 | EP1623990A2 Compositions and methods for the treatment of tumours |
| 02/08/2006 | EP1623989A1 Compositions and methods for the diagnosis of tumours |
| 02/08/2006 | EP1623764A2 Automated process for isolating and amplifying a target nucleic acid sequence |
| 02/08/2006 | EP1623352A2 Computational methods and systems for multidimensional analysis |
| 02/08/2006 | EP1623351A2 Computational method and system for mass spectral analysis |
| 02/08/2006 | EP1623234A2 Determination of analyte characteristics based upon binding properties |
| 02/08/2006 | EP1623230A2 Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor gpr39 (gpr39) |
| 02/08/2006 | EP1623224A2 Biocompatible sensor electrode assembly and method for the production thereof |
| 02/08/2006 | EP1623222A2 Ranbp2 as modifier of the pten/igf pathway and methods of use |
| 02/08/2006 | EP1623046A2 Compositions and methods for the treatment of severe acute respiratory syndrome (sars) |
| 02/08/2006 | EP1623045A2 Biological bar-code |
| 02/08/2006 | EP1623044A2 Methods for amplification of nucleic acid sequences using staggered ligation |
| 02/08/2006 | EP1623043A1 Method for the identification of cell lineages |
| 02/08/2006 | EP1623042A1 One step oligochromatographic device and method of use |
| 02/08/2006 | EP1623041A1 Method of diagnosing a genetic susceptibility for bone damage |
| 02/08/2006 | EP1623040A1 Fluorescent methods for the high-throughput quantification of tartrate-resistant acid phosphatase (trap) |
| 02/08/2006 | EP1623039A2 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| 02/08/2006 | EP1623025A1 Glucose dehydrogenase and production thereof |
| 02/08/2006 | EP1623020A2 Genomic and proteomic approaches for the development of cell culture medium |
| 02/08/2006 | EP1623018A2 Mptens as modifiers of the pten/igf pathway and methods of use |
| 02/08/2006 | EP1623013A2 Methods for identification of coronaviruses |
| 02/08/2006 | EP1623010A2 Preservation of rna in a biological sample |
| 02/08/2006 | EP1623009A2 Transfection kinetics and structural promoters |
| 02/08/2006 | EP1623004A2 Genetic markers for skatole metabolism |
| 02/08/2006 | EP1622940A1 Analysis and use of par 1 polymorphisms for the risk estimation of cardiovascular diseases |
| 02/08/2006 | EP1622923A2 Molecular detection systems utilizing reiterative oligonucleotide synthesis |
| 02/08/2006 | EP1622921A2 Variants of beta-glucosidases |
| 02/08/2006 | EP1622684A2 Compositions and methods relating to novel compounds and targets thereof |
| 02/08/2006 | EP1622638A2 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use |
| 02/08/2006 | EP1622634A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/08/2006 | EP1622589A1 Compositions, targets, methods and devices for the therapy of ocular and periocular disorders |
| 02/08/2006 | EP1622500A2 Parallel analysis of molecular interactions |
| 02/08/2006 | EP1546346A4 Embryonic stem cell markers and uses thereof |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1442126B1 Method for selecting genetically transformed cells |
| 02/08/2006 | EP1436618A4 Muscle sample prepared for prion assay |
| 02/08/2006 | EP1419274A4 Modular assembly of nucleic acid-protein fusion multimers |
| 02/08/2006 | EP1414998A4 Methods for the identification of inhibitors of ferredoxin nadp oxidoreductase expression or activity in plants |
| 02/08/2006 | EP1373569A4 Pcr method |
| 02/08/2006 | EP1337651B1 Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae |
| 02/08/2006 | EP1336101B1 A method to measure the activation state of signaling pathways in cells |
| 02/08/2006 | EP1297006B1 Regulation of human prostasin-like serine protease |
| 02/08/2006 | EP1289642B1 Nanocapsules having a polyelectrolyte envelope |
| 02/08/2006 | EP1274860A4 Use of genetic markers to diagnose familial dysautonomia |
| 02/08/2006 | EP1155148B1 Detection and quantification of micro-organisms using amplification and restriction enzyme analysis |
| 02/08/2006 | EP1137802B1 Method for determining the activity of a substance using a functional test in vitro |
| 02/08/2006 | EP1112362B1 GENE MODIFICATION IN THE GENE FOR THE DIE G$g(b)3-SUB-UNIT OF HUMAN G-PROTEIN |
| 02/08/2006 | EP1108058B1 Evolution of whole cells and organisms by recursive sequence recombination |
| 02/08/2006 | EP1088104B1 Methods for treating a neurological disease by determining bche genotype |
| 02/08/2006 | EP1080227B1 Method of diagnosing, monitoring, and staging colon cancer |
| 02/08/2006 | EP1068297B1 Use of monocytes derived cells, antigens and antibodies for optimal induction of immunotherapeutic efficiency |
| 02/08/2006 | EP1023461B1 Methods for determining coat colour genotypes in pigs |
| 02/08/2006 | EP0996742A4 Methods for cleaving dna with nucleotide integrases |
| 02/08/2006 | EP0969855B1 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/08/2006 | EP0842299B1 Atopy: diagnosis and therapy |
| 02/08/2006 | EP0812356B1 Prostate-specific membrane antigen and uses thereof |
| 02/08/2006 | EP0765391B1 Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 02/08/2006 | EP0694067B1 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 02/08/2006 | CN1732724A Apparatus and method for controlling registration of print steps in a continuous process for the manufacture of electrochemical sensors |
| 02/08/2006 | CN1732273A Combined exponential and linear amplification |
| 02/08/2006 | CN1732272A Assay for rnase h activity |
| 02/08/2006 | CN1732271A Methods and compositions for detecting telomerase activity |
| 02/08/2006 | CN1732270A ACTN3 genotype screen for athletic performance |
| 02/08/2006 | CN1732269A Cooling stations for use in a web printing process for the manufacture of electrochemical sensors |
| 02/08/2006 | CN1732181A Nucleotide derivatives and DNA microarray |
| 02/08/2006 | CN1732018A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/08/2006 | CN1731179A A method for detecting abnormality rate of refrigerated cattle semen |